Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CHD1L encodes a DNA helicase protein involved in DNA repair. Additionally we are shipping CHD1L Kits (3) and CHD1L Proteins (3) and many more products for this protein.
Showing 10 out of 40 products:
Human Polyclonal CHD1L Primary Antibody for EIA, WB - ABIN951497
Chen, Chan, Yuan, Hu, Huang, Ma, Wang, Dong, Tang, Xie, Li, Guan: CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. in The Journal of clinical investigation 2010
Show all 4 references for ABIN951497
Overexpression of CHD1L is positively associated with tumor metastasis of lung adenocarcinoma, and might serve as a novel prognostic biomarker and potential therapeutic target for patients.
This study identified CHD1L as a potential anti-metastasis target for therapeutic intervention in breast cancer.
Relative mRNA expression level of CHD1L was higher in breast cancer cell lines.
These results indicated that CHD1L could serve as a prognostic marker for gastric cancer
CHD1L is now considered to be a novel independent biomarker for progression, prognosis and survival in several solid tumors. [Review]
Data indicate that chromodomain helicase/ATPase (show DNAH8 Antibodies) DNA-binding protein (show UBE2V1 Antibodies) 1-like (CHD1L) might be an diagnostic and prognostic marker for bladder cancer (BC) patients.
TRIM33 (show TRIM33 Antibodies) plays a role in PARP (show COL11A2 Antibodies)-dependent DNA damage response and regulates ALC1 (show MYL4 Antibodies) activity by promoting its timely removal from sites of DNA damage.
CHD1L is the target oncogene (show RAB1A Antibodies) within the 1q21 amplicon and plays a pivotal role in colorectal carcinoma pathogenesis.
positive expression of CHD1L protein is significantly correlated with the metastasis proceeding of ovarian carcinoma, and CHD1L protein expression, as examined by IHC, may act as a novel prognostic biomarker for patients with ovarian carcinoma.
the model that PAR (show JTB Antibodies) present on PARylated PARP1 (show PARP1 Antibodies) acts as an allosteric effector of ALC1 (show MYL4 Antibodies) nucleosome remodeling activity.
found a significant correlation of CHD1L with developmental transcriptional factors and lineage differentiation markers in clinical hepatocellular carcinoma patients
these results identify CHD1L as a key chromatin remodeler involved in PARP1 (show PARP1 Antibodies)/PARylation-regulated early-stage reprogramming and pluripotency in stem cells.
TRIM33 (show TRIM33 Antibodies) plays a role in PARP (show PARP1 Antibodies)-dependent DNA damage response and regulates ALC1 (show MYL4 Antibodies) activity by promoting its timely removal from sites of DNA damage.
CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Reports that transgenic CHD1L (Alc1) expression induces spontaneous tumors in mice.
This gene encodes a DNA helicase protein involved in DNA repair. The protein converts ATP to add poly(ADP-ribose) as it regulates chromatin relaxation following DNA damage. Several alternatively spliced transcripts variants have been described for this gene.
chromodomain helicase DNA binding protein 1-like
, chromodomain-helicase-DNA-binding protein 1-like
, amplified in liver cancer 1
, amplified in liver cancer protein 1